AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 261: H1864-H1871, 1991;
0363-6135/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitani, A.
Right arrow Articles by Tokunaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitani, A.
Right arrow Articles by Tokunaga, K.

AJP - Heart and Circulatory Physiology, Vol 261, Issue 6 1864-H1871, Copyright © 1991 by American Physiological Society


ARTICLES

Effects of glibenclamide and nicorandil on cardiac function during ischemia and reperfusion in isolated perfused rat hearts

A. Mitani, K. Kinoshita, K. Fukamachi, M. Sakamoto, K. Kurisu, Y. Tsuruhara, F. Fukumura, A. Nakashima and K. Tokunaga
Division of Cardiovascular Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

We examined influences of a blocker (glibenclamide) and an opener (nicorandil) of the ATP-sensitive potassium (KATP) channel on extracellular K concentration [( K+]e), as well as the myocardial function and metabolites during global ischemia and reperfusion in Langendorff-perfused rat heart preparation. In control hearts, [K+]e began to rise 20 s after the onset of ischemia up to an initial peak (8.3 +/- 0.3 mM) at 2.5 +/- 0.7 min, then fell to 6.0 +/- 0.8 mM after 8.2 +/- 0.7 min, and then rose progressively to 14.6 +/- 0.8 mM at the end of 30 min of ischemia. Glibenclamide (50 microM) reduced the initial peak of [K+]e to 7.2 +/- 0.3 mM (P less than 0.01), and nicorandil (200 microM) increased it to 9.4 +/- 0.6 mM (P less than 0.01). There were no significant differences in [K+]e values among all groups at the end of ischemia. During ischemia, nicorandil decreased the time to mechanical arrest from 1.9 +/- 0.1 min to 1.5 +/- 0.1 min, whereas it was increased by glibenclamide to 2.7 +/- 0.4 min. In control hearts, the time to onset of ischemic contracture was 14.7 +/- 1.8 min. Nicorandil delayed onset of contracture and glibenclamide accelerated it. Thus we have confirmed that some part of the early increase in [K+]e during ischemia is attributable to K+ efflux through the KATP channel in our model, and opening of the KATP channel may contribute to a rapid reduction of the contractility of the ischemic myocardium that subsequently protects the myocardium against further ischemic injury.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. R. Terkildsen, E. J. Crampin, and N. P. Smith
The balance between inactivation and activation of the Na+-K+ pump underlies the triphasic accumulation of extracellular K+ during myocardial ischemia
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3036 - H3045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Saito, T. Sato, T. Miki, S. Seino, and H. Nakaya
Role of ATP-sensitive K+ channels in electrophysiological alterations during myocardial ischemia: a study using Kir6.2-null mice
Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H352 - H357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, N. S. Gauthier, R. Morrison, and G. P. Matherne
Cardioprotection by KATP channels in wild-type hearts and hearts overexpressing A1-adenosine receptors
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1690 - H1697.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Sato, J. Yamazaki, and T. Nagao
Temporal Differences in Actions of Calcium Channel Blockers on K+ Accumulation, Cardiac Function, and High-Energy Phosphate Levels in Ischemic Guinea Pig Hearts
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 831 - 839.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
A. W. Gomoll, R. A. Roth, R. E. Swillo, A. J. Baird, C. S. Sargent, R. W. Behling, H. J. Malone, and G. J. Grover
Effect of Timing of Treatment of the Glyburide-Reversible Cardioprotective Activity of BMS-180448
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 24 - 33.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Kanda, I. Watanabe, M. L. Williams, C. L. Engle, S. Li, G. G. Koch, and L. S. Gettes
Unanticipated Lessening of the Rise in Extracellular Potassium During Ischemia by Pinacidil
Circulation, April 1, 1997; 95(7): 1937 - 1944.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Yamashita, R. A. Schmid, S. Fujino, J. D. Cooper, and G. A. Patterson
NICORANDIL, A POTENT ADENOSINE TRIPHOSPHATE-SENSITIVE POTASSIUM-CHANNEL OPENER, AMELIORATES LUNG ALLOGRAFT REPERFUSION INJURY
J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1307 - 1314.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. S. Lawton, G. C. Harrington, C. T. Allen, P.-W. Hsia, and R. J. Damiano Jr
Myocardial Protection With Pinacidil Cardioplegia in the Blood-Perfused Heart
Ann. Thorac. Surg., June 1, 1996; 61(6): 1680 - 1688.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Qiu, M. Galinanes, and D. J. Hearse
PROTECTIVE EFFECT OF NICORANDIL AS AN ADDITIVE TO THE SOLUTION FOR CONTINUOUS WARM CARDIOPLEGIA
J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1063 - 1072.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Sugimoto, P. E. Puddu, F. Monti, M. Schiariti, P. P. Campa, and B. Marino
Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia
J. Thorac. Cardiovasc. Surg., September 1, 1994; 108(3): 455 - 466.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online